
Synovathera Services
Our Approach
We provide an integrated, end-to-end solution that unlocks Canadian access for high-quality pharmaceuticals, biologics, digital therapeutics (SaMD), and AI-health technologies.
-
Key Pillars:
-
Regulatory-First Market Entry: Navigate Health Canada, CDA, INESSS, and PMPRB requirements
-
Payer-Aligned Commercialization: Align clinical evidence with reimbursement priorities
-
Pilot-to-Revenue Conversion: Turn pilots into reimbursed uptake through Clarity Intelligence™
Built for Canada: Deep experience in health systems, pricing controls, and PSPs.
Our Mission
We expand patient access to life-changing therapies by connecting global innovators with the Canadian market through regulatory-first, payer-aligned commercialization.
Synovathera empowers companies to enter Canada without delay or distraction, delivering local execution that bridges the gap between clinical promise and reimbursed access
Leadership
Our leadership team brings decades of hands-on success across go-to-market execution, regulatory strategy, clinical development, and product commercialization, spanning both breakthrough innovations and mature brand portfolios.
Commercialization
Our team has forged high-trust collaborations across the Canadian healthcare landscape:
-
Clinicians & KOLs to drive awareness and adoption
-
Payers & Policymakers, to secure reimbursement and coverage
-
Distributors, PSPs, and Specialty Pharmacies, to enable seamless patient access
-
Government & Innovation Hubs , to align with policy and procurement trends
Partnering
We partner with innovators and global leaders in pharma, biotech, AI-health, and medtech to unlock revenue and market share in Canada.
From strategic planning to hands-on execution, we accelerate adoption, reimbursement, and real-world impact, backed by deep expertise and a high-trust national network.
What We Deliver
1. In-Licensing & Strategic Partnerships
For global firms seeking a partner
We serve as your on-the-ground execution arm:
-
Pharmaceuticals & Biologics
-
AI-Enabled SaMD & Digital Health
-
Medtech and Advanced Diagnostics
2. Full-Service Commercialization
We handle everything from regulatory alignment to product launch and sustained market growth:
-
Launch planning and GTM strategy
-
MSL and key account team deployment
-
Clinical, HEOR, and reimbursement evidence development
-
Payer dossier preparation and HTA submission
3. Clarity Intelligence™
Our proprietary HITL (human-in-the-loop) platform provides investor-grade clarity:
-
Monte Carlo-based scenario planning
-
Sequencing, price corridor, and indication prioritization
-
Conversion tracking from pilot to payer adoption
4. Patient Support Programs
We design, run, and hand over regulatory-first, payer-aligned PSPs:
-
Bilingual onboarding & consent; benefits investigation & case management
-
Prior auth & reimbursement pull-through; bridge/start & copay support
-
Nurse training; injection/infusion coordination; cold-chain logistics
-
Digital adherence & outcomes; biosimilar switch protocols
Access & Distribution Integration
5. Distribution and coverage commitments:
We align:
-
Integration with specialty distributors and pharmacies
-
Start-of-care aligned to pCPA/PLA SLAs and provincial listing dates
-
Privacy-by-design (consent, AE capture, recall readiness)
-
Clinic-friendly forms, ePA integrations, scheduling & inventory visibility
6. Governance, SOPs & Vendor Oversight
We operationalize compliance so field work converts to persistency:
-
SOP suite, Quality Agreements, PV routing, and audit trails
-
Vendor selection, SLAs, and KPI dashboards (time-to-first-dose, persistency)
-
Data stewardship, de-identification, and secure reporting

Our Core Offerings


Canada is Complex
Success demands trust, relationships, and alignment across the ecosystem:
-
Clinicians & KOLs → drive clinical awareness-
-
Payers & Policymakers → secure access and budgets
-
PSPs & Pharmacies → ensure continuity and adherence
-
Distributors & Government → support scale-up and procurement
Embedded Expertise
Led by professionals with decades of commercialization experience across global pharma, medtech, and AI-health:
-
Proven track record with CDA, PMPRB, and provincial negotiations
-
Strong network across Canadian regulators, payers, and providers
-
Tactical know-how to execute—not just advise

Who We Work With
-
Global Innovators seeking Canadian market entry
-
Investors looking to validate pipeline readiness
-
HealthTech Companies needing local infrastructure
-
Commercial Teams requiring execution support without full-scale buildout
From advisory to embedded teams, Synovathera delivers outcomes, not overhead.

Outcomes That Matter
-
Accelerated time-to-access and market adoption
-
Lower reimbursement and pricing risk
-
Increased forecast accuracy and strategic optionality
-
Faster path to cash-positive operations in Canada
Let’s Talk
Ready to commercialize in Canada?